Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on February 12, 2008
JNCI Journal of the National Cancer Institute 2008 100(4):227; doi:10.1093/jnci/djn047
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/4/227-b    most recent
djn047v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Savage, L.
Right arrow Articles by Widener, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Savage, L.
Right arrow Articles by Widener, A.
Related Collections
Right arrowRelated Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

MEMO TO THE MEDIA

HPV-Positive Head and Neck Cancer Patients Fare Better than HPV-Negative Patients

Liz Savage, Andrea Widener

jncimedia@oxfordjournals.org
301-841-1287

The first 10% of the full text of this article appears below.

Head and neck cancer patients with HPV-positive tumors tend to survive longer and are more responsive to treatment compared with patients with HPV-negative tumors, according to a study published online February 12 in the Journal of the National . . . [Full Text of this Article]

Contact:

Citation:

Note to Reporters:


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

Re: Intravenous Bisphosphonate Therapy and Inflammatory Conditions or Surgery of the Jaw: A Population-Based Analysis
Mogher Khamaisi and Sharon Elad
J Natl Cancer Inst 2008 100: 155. [Extract] [Full Text] [PDF]